- mail us help@24marketresearch.com
- Int'l 1(332) 2424 294 (Int'l)
TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
The global Pharmacovigilance Software market was valued at US$ 176.6 million in 2022 and is projected to reach US$ 258.7 million by 2029, at a CAGR of 5.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
It manages all Adverse Events regarding drugs, devices, vaccines, biologics, cosmetics and nutritional supplements.
This report aims to provide a comprehensive presentation of the global market for Pharmacovigilance Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacovigilance Software. This report contains market size and forecasts of Pharmacovigilance Software in global, including the following market information:
Global Pharmacovigilance Software Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
ADR Reporting Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pharmacovigilance Software include United BioSource Corporation, Sparta Systems, Oracle Corporation, Ennov Solutions, Max Application, EXTEDO GmbH, AB Cube, Relsys and Online Business Applications, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pharmacovigilance Software companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Chapter 1: Introduces the definition of Pharmacovigilance Software, market overview.
Chapter 2: Global Pharmacovigilance Software market size in revenue.
Chapter 3: Detailed analysis of Pharmacovigilance Software company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmacovigilance Software in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.